Global Market Study on Animal Drug Compounding: Antiinflammatory Agents Product Type Segment Projected to Hold Significant Market Share During 2016-2024 With the decreasing number of animals over the years, the compounded drugs for animals are likely to witness relatively more demand in the coming years. However, compounding drugs are not the only option for veterinarians to treat animals that need pro-kinetic drug therapy. The U.S. FDA highlights few critical animal shortages that include 35% Perox Aid, Epinephrine and Flunixine Injectable. The global animal drug compounding market is expected to witness a growth of 6.3% CAGR over the forecast period, 2016-2024. Market Dynamic Increasing availability and preference for flavored dosages will fuel demand for animal drug compounding in the coming years. In addition, for convenience in consumption, the veterinary drug compounders are likely to offer medicines that taste less bitter, creamy, non-gritty and smooth. Such factors contribute majorly towards enhanced patient compliance, and is likely to impact growth of the global market positively in the coming years. Attributed to increasing availability of dosages that are flavored, the animal drug compounding market is likely to witness a significant growth over the coming years. Furthermore, surge in availability and preference of accreditation has revved up the prospects of sales prospects for compounded animal drugs. In addition, relatively low availability of substitutes of veterinary drugs that are generic is likely to contribute towards growth of the global animal drug compounding market in the coming years. Browse Full Research Report: https://www.persistencemarketresearch.com/market-research/animal-drugcompounding-market.asp Segmentation Analysis CNS agents among others will account for revenue share of over 37% globally, and will witness a growth at a CAGR of 7.8% in terms of revenue in the span of next seven years. Companion animals will further hold revenue share of 47% globally, whereas dogs will account for major application of compounded drugs for companion animals in the coming years. Over half of the market value will be held by the sales of compound drugs for livestock animals. However, market presence of compound drugs for livestock animals will witness a drop as compared to other alternatives by the end of 2024. Furthermore, orally formulated drugs will hold above 80% of the value in animal drug compound market over the coming years. Request and Download Sample Report@ https://www.persistencemarketresearch.com/samples/12871 Regional Analysis The animal drug compounding market in North America will witness a growth of 7% CAGR in terms of revenue in the span of next seven years. Moreover, Canada and U.S. will account for over two-third of the sales of compound animal drugs over the coming years. However, the other parts of the world will witness relatively slow growth in terms of demand for animal drug compounding in the coming years. The other parts of the world will witness a CAGR growth of less than 5% in the coming years. Market Players Leading manufacturers operating in the global animal drug compound market include Lorraine’s Pharmacy, Triangle Compounding Pharmacy Inc., WEDGEWOOD PHARMACY, Medisca Inc., ESSENTIAL PHARMACY COMPOUNDING VET (Kohll’s Pharmacy & Homecare), Slade Dispensary Services and Diamondback Drugs LLC. Buy Full Animal Drug Compounding Market Report @ https://www.persistencemarketresearch.com/checkout/12871 About Us Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance. To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes. Contact Us Persistence Market Research 305 Broadway 7th Floor, New York City, NY 10007, United States, USA – Canada Toll Free: 800-961-0353 Email: sales@persistencemarketresearch.com Web: http://www.persistencemarketresearch.com

According to Persistence Market Research’s report, titled “Animal Drug Compounding Market: Global Industry Analysis and Forecast, 2016-2024,” more than two-third of global sales of compounded animal drugs will remain concentrated in the US and Canada.